Access to medicines and intellectual property in Jordan

23-July-2012

Delayed market entry of generics due to enhanced intellectual property protection cost Jordanian private consumers approximately 18 million US dollars annually

Post a comment

Who are you?
Your post
  • To create paragraphs, just leave blank lines.